Left Menu
Development News Edition

WHO ending hydroxychloroquine trial for COVID

The World Health Organization says it is ending a trial into whether anti-malaria drug hydroxychloroquine helps patients hospitalised with COVID-19. WHO says the decision won't affect possible trials on patients who aren't hospitalized, or on those receiving the drugs before potential exposure to the coronavirus or shortly afterward.

PTI | Berlin | Updated: 05-07-2020 12:48 IST | Created: 05-07-2020 09:08 IST
WHO ending hydroxychloroquine trial for COVID
Representative Image Image Credit: ANI

The World Health Organization says it is ending a trial into whether anti-malaria drug hydroxychloroquine helps patients hospitalised with COVID-19. WHO said Saturday it has "accepted the recommendation" from the committee overseeing the trial to discontinue testing of hydroxychloroquine and lopinavir/ritonavir, a drug combination used to treat HIV/AIDS. The drugs were being compared with standard care for hospitalized patients.

WHO says a review of the interim results showed hydroxychloroquine and lopinavir/ritonavir "produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care." The agency adds that while there was no "solid evidence" of increased mortality for hospitalized patients given the drugs, there were "some associated safety signals in the clinical laboratory findings" of an associated trial. WHO says the decision won't affect possible trials on patients who aren't hospitalized, or on those receiving the drugs before potential exposure to the coronavirus or shortly afterward.


TRENDING

OPINION / BLOG / INTERVIEW

5G will be the key driving force for COVID-19 recovery: Here's how?

... ...

Canada’s COVID-19 pitfalls highlight need for integrated health information system

In the globalized world of today where outbreaks can spread far and wide within a matter of days, a global-level integrated health information system is ideal but Canadas provincial barriers show that the country lags much behind in deployi...

Pandemic must be impetus, not obstacle, for clean water access

To make matters worse, there are suspicions that the inadequacy of wastewater treatment methods in California, the rest of the USA, and indeed around the world may help to propagate the disease even more widely. ...

3D printing and the future of manufacturing post COVID-19

The on-demand, customizable, and localized manufacturing of product components facilitated by 3D printing has the potential to redefine manufacturing but there are certain technical, mechanical, and legal limitations that, unless ...

Videos

Latest News

Lockdown extended in Manipur till Aug 31 amid rising COVID-19 cases

The Manipur government on Saturday extended the complete lockdown till August 31 to contain the spread of COVID-19 in the state, where 192 more people tested positive, pushing the tally to 4,390. A state government directive also asked depu...

Report: Packers sign NT Clark to $70M extension

The Green Bay Packers are set to make Kenny Clark the highest-paid nose tackle ever. Clark, who was set to begin the final year of his rookie contract, will receive 70 million over four years, according to Ian Rapoport and Tom Pelissero of ...

Biden promises to reform H-1B visa system, eliminate country quota for Green Cards

If voted to power in the November general elections, a Biden administration will reform the H-1B visa system and work towards eliminating the country-quota system for Green Cards, his campaign said on Saturday, in a move to woo the influent...

Rescue workers pull out bus from waterlogged Surat street

Rescue workers pulled out a bus from severely waterlogged streets in Surat on Saturday after heavy monsoon rains poured in the area.Visuals from the area showed the workers pulling out the bus using ropes while navigating through knee-deep ...

Give Feedback